Combination Drug to Treat Cholesterol Disorders - Brief Article

Author: Elaine Kierl Gangel
Date: March 15, 2002

The U.S. Food and Drug Administration has approved extended-release niacin/lovastatin tablets (Advicor), the first combination therapy for the treatment of cholesterol disorders. It is indicated for use in patients with hypercholesterolemia and mixed dyslipidemia who have been previously treated with either component and who require more lipid modification than was achieved by the individual components.

COPYRIGHT 2002 American Academy of Family PhysiciansCOPYRIGHT 2002 Gale Group

© 2006,, All Rights Reserved.